Question 1

Does Goldman Sachs Group own VKTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs Group holds 942,841 shares of VKTX (Viking Therapeutics), worth $36.8M.

Question 2

How many shares of VKTX does Goldman Sachs Group own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group holds 942,841 shares of VKTX (Viking Therapeutics).

Question 3

What is Goldman Sachs Group's VKTX position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group's VKTX position is worth $36.8M.

Question 4

Is Goldman Sachs Group buying or selling VKTX?

Accepted Answer

In Q2 2026, Goldman Sachs Group reduced its VKTX position by 17,729 shares (-1.9%).

Question 5

When did Goldman Sachs Group first buy VKTX?

Accepted Answer

Goldman Sachs Group already held VKTX in its Q2 2022 13F, the earliest on record, and has listed it in 17 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	942,841	-1.9%	$36.8M	0.0%	$39.01	0
2026-Q1	Increased	960,570	+15.4%	$31.3M	0.0%	$32.54	33
2025-Q4	Increased	832,651	+211.0%	$29.3M	0.0%	$35.18	46
2025-Q3	Increased	267,744	+74.5%	$7M	0.0%	$26.28	41
2025-Q2	Increased	153,418	+10.1%	$4.1M	0.0%	$26.50	29
2025-Q1	Increased	139,355	+37.0%	$3.4M	0.0%	$24.15	35
2024-Q4	Decreased	101,702	-35.1%	$4.1M	0.0%	$40.24	0
2024-Q3	Decreased	156,719	-85.4%	$9.9M	0.0%	$63.31	0